Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
910.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 8.00 (0.879%)
Market Cap: £495.14m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate Change

22 Jan 2025 15:48

RNS Number : 3399U
JPMorgan Claverhouse IT PLC
22 January 2025
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Tom Smethers as a Non-Executive Director of the Company with effect from 3rd February 2025.

 

Mr. Smethers is an experienced finance professional, with a strong background in the FMCG, retail, hospitality and aviation sectors. Mr. Smethers has led major transformation projects, handled multiple M&A processes, and has international experience across Europe, the Middle East, and Australia.

Mr. Smethers was previously a Non-Executive Director and Audit Committee Chair of Artemis Alpha Trust plc and is currently a trustee of the charity, Wings for Warriors. He is presently the Chief Financial Officer at Carlsberg Britvic plc and held senior positions at Costa Coffee, TUI Group, Jumeirah Group LLC, and easyJet plc.

 

Mr. Smethers is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

Mr. Smethers does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Smethers.

 

 

22nd January 2025

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDBRSDDGUD
Date   Source Headline
20th Nov 202410:55 amRNSNet Asset Value(s)
19th Nov 202411:07 amRNSNet Asset Value(s)
18th Nov 20245:31 pmRNSTransaction in Own Shares
18th Nov 202412:15 pmRNSGearing announcement
18th Nov 202411:51 amRNSNet Asset Value(s)
15th Nov 202411:05 amRNSNet Asset Value(s)
14th Nov 202410:55 amRNSNet Asset Value(s)
13th Nov 202410:45 amRNSNet Asset Value(s)
12th Nov 202411:16 amRNSNet Asset Value(s)
11th Nov 20244:02 pmRNSTen Largest Investments
11th Nov 20241:34 pmRNSGearing announcement
11th Nov 202411:09 amRNSNet Asset Value(s)
8th Nov 202411:43 amRNSNet Asset Value(s)
7th Nov 202411:10 amRNSNet Asset Value(s)
6th Nov 202410:46 amRNSNet Asset Value(s)
5th Nov 202410:49 amRNSNet Asset Value(s)
4th Nov 202412:26 pmRNSGearing announcement
4th Nov 202411:13 amRNSNet Asset Value(s)
1st Nov 202411:43 amRNSNet Asset Value(s)
1st Nov 20249:16 amRNSTotal Voting Rights
31st Oct 20245:14 pmRNSTransaction in Own Shares
31st Oct 202410:44 amRNSNet Asset Value(s)
30th Oct 20244:42 pmRNSDividend Declaration (Replacement)
30th Oct 202411:49 amRNSNet Asset Value(s)
29th Oct 202412:05 pmRNSNet Asset Value(s)
28th Oct 20246:17 pmRNSDividend Declaration
28th Oct 202412:09 pmRNSGearing announcement
28th Oct 202410:50 amRNSNet Asset Value(s)
25th Oct 202411:31 amRNSNet Asset Value(s)
24th Oct 202410:33 amRNSNet Asset Value(s)
23rd Oct 202410:57 amRNSNet Asset Value(s)
22nd Oct 20244:52 pmRNSTransaction in Own Shares
22nd Oct 202410:57 amRNSNet Asset Value(s)
21st Oct 202411:35 amRNSGearing Announcement
21st Oct 202410:50 amRNSNet Asset Value(s)
18th Oct 202411:41 amRNSNet Asset Value(s)
17th Oct 20245:03 pmRNSTransaction in Own Shares
17th Oct 202411:13 amRNSNet Asset Value(s)
16th Oct 20244:37 pmRNSTransaction in Own Shares
16th Oct 202410:59 amRNSNet Asset Value(s)
15th Oct 20244:55 pmRNSTransaction in Own Shares
15th Oct 202411:33 amRNSNet Asset Value(s)
14th Oct 202411:27 amRNSGearing announcement
14th Oct 202410:14 amRNSNet Asset Value(s)
11th Oct 20245:17 pmRNSTransaction in Own Shares
11th Oct 202411:28 amRNSNet Asset Value(s)
10th Oct 20242:31 pmRNSTop Ten Largest Investments
10th Oct 202411:42 amRNSNet Asset Value(s)
9th Oct 202411:04 amRNSNet Asset Value(s)
8th Oct 202410:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.